NIH funding by institute · Fiscal year 2026
National Institute on Drug Abuse (NIDA) Grants and Funding
Reviewed by Dr. Meng ZhaoLast reviewed October 26, 2026Data refreshed October 16, 2026Editorial standards
NIDA administered $1.31B in fiscal year 2026 across 2,053 award records to 220 institutions with $10M or more in NIH funding, down 1.4% from FY2025. Yale University received the most, 4.9% of that total.
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
FY2026 NIDA funding
$1.31B
−1.4% vs FY2025
Award records
2,053
Institutions funded
220
Recipients with $10M+ in NIH funding
Open or upcoming NOFOs
104
NIDA as lead or participating institute
Top NIDA-funded institutions, FY2026
| # | Institution | NIDA FY2026 | vs FY2025 | Awards | Share |
|---|---|---|---|---|---|
| 1 | Yale UniversityNew Haven, CT | $64.3M | −10.7% | 82 | 4.9% |
| 2 | University of California San DiegoLa Jolla, CA | $63.6M | +2.7% | 73 | 4.9% |
| 3 | Johns Hopkins UniversityBaltimore, MD | $51.4M | +0.7% | 73 | 3.9% |
| 4 | Washington University in St. LouisSaint Louis, MO | $44.6M | +17.1% | 43 | 3.4% |
| 5 | University of MichiganAnn Arbor, MI | $33.3M | +19.0% | 47 | 2.5% |
| 6 | University of PittsburghPittsburgh, PA | $30.1M | −1.9% | 48 | 2.3% |
| 7 | NYU Grossman School of MedicineNew York, NY | $29.8M | −3.1% | 29 | 2.3% |
| 8 | University of WashingtonSeattle, WA | $27.2M | −19.8% | 49 | 2.1% |
| 9 | Icahn School of Medicine at Mount SinaiNew York, NY | $26.8M | +20.4% | 44 | 2.1% |
| 10 | University of California, San FranciscoSan Francisco, CA | $25.9M | +15.9% | 49 | 2.0% |
| 11 | Medical University of South CarolinaCharleston, SC | $21.7M | +25.7% | 37 | 1.7% |
| 12 | Stanford UniversityStanford, CA | $20.2M | +13.9% | 28 | 1.5% |
| 13 | University of KentuckyLexington, KY | $19.8M | +29.8% | 30 | 1.5% |
| 14 | University of MinnesotaMinneapolis, MN | $19.3M | +12.7% | 38 | 1.5% |
| 15 | Virginia Commonwealth UniversityRichmond, VA | $17.7M | −6.3% | 38 | 1.4% |
| 16 | Oregon Health & Science UniversityPortland, OR | $16.8M | +13.7% | 29 | 1.3% |
| 17 | Wake Forest University Health SciencesWinston-Salem, NC | $15.6M | −13.7% | 32 | 1.2% |
| 18 | University of California, Los AngelesLos Angeles, CA | $15.5M | −11.2% | 32 | 1.2% |
| 19 | University of Colorado Anschutz Medical CampusAurora, CO | $15.4M | +18.1% | 25 | 1.2% |
| 20 | Rutgers Biomedical and Health SciencesNewark, NJ | $15.1M | +5.4% | 31 | 1.2% |
| 21 | University of Maryland, BaltimoreBaltimore, MD | $14.8M | −8.2% | 28 | 1.1% |
| 22 | University of Miami Miller School of MedicineCoral Gables, FL | $14.8M | +14.9% | 21 | 1.1% |
| 23 | University of Alabama at BirminghamBirmingham, AL | $14.6M | +25.1% | 29 | 1.1% |
| 24 | Research Triangle InstituteResearch Triangle Park, NC | $14.5M | −13.3% | 15 | 1.1% |
| 25 | Boston Medical CenterBoston, MA | $14.5M | +77.4% | 21 | 1.1% |
Showing the 25 largest of 220 institutions with NIDA funding.
Open and upcoming NIDA funding opportunities
NOFOs led by NIDA first, then those NIDA participates in, soonest due date first. Browse every NIH NOFO.
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
PAR-27-053 · R61, R33
Next due Nov 2, 2026
Next due Nov 18, 2026
- Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
RFA-DA-26-055 · R01
Next due Dec 3, 2026
- Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
RFA-DA-26-056 · R21
Next due Dec 3, 2026
- HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)
RFA-DA-28-011 · RM1 · opens soon
Next due Jan 26, 2027
- HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)
RFA-DA-28-012 · U2C · opens soon
Next due Jan 26, 2027
- Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)
RFA-DA-28-013 · U01 · opens soon
Next due Feb 8, 2027
- HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
RFA-DA-27-016 · R61, R33
Next due Feb 10, 2027
- Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)
PAR-28-093 · R34 · opens soon
Next due Feb 16, 2027
- Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
PAS-27-028 · R03
Next due Feb 16, 2027
Next due Feb 16, 2027
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
PAR-25-100 · R34
Next due Feb 16, 2027
- Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
PAR-25-446 · UG3, UH3
Next due Feb 22, 2027
Next due Mar 10, 2027
Next due Apr 15, 2027
Showing 15 of 104. See all NIDA NOFOs.
Recent NIDA awards
The newest NIDA award notices among the institutions above, each linked to its NIH RePORTER record.
- Development of a Novel Treatment for Benzodiazepine Addiction (opens NIH RePORTER)
University of Mississippi Medical Center · 1UG3DA065285-01A1 · NIDA · Notice Sep 18, 2026
$1.8MUG3
- Mechanistic Evaluation of Psilocybin in Opioid Use Disorder: A Randomized, Double-Blind, Active-Placebo-Controlled Crossover Trial with Pharmacokinetic/Pharmacodynamic Modeling (opens NIH RePORTER)
Johns Hopkins University · 1R01DA066503-01 · NIDA · Notice Sep 18, 2026
$684KR01
- Incorporating real-world patient and clinician preferences in simulating Integrated Models of Prenatal care for Addiction and Hepatitis C Treatment (IMPACT) (opens NIH RePORTER)
Boston Medical Center · 1R01DA066594-01 · NIDA · Notice Sep 17, 2026
$847KR01
- Cannabis use effects on mGlu5 and related neurocognition in humans (opens NIH RePORTER)
Yale University · 1R01DA064913-01 · NIDA · Notice Sep 17, 2026
$838KR01
- Longitudinal Trajectories of OUD Care following Initial Engagement with a Low-Threshold Bridge Clinic (opens NIH RePORTER)
Massachusetts General Hospital · 1R01DA065550-01 · NIDA · Notice Sep 17, 2026
$777KR01
- Personalized Reinforcement Learning-Based Integrated Mental Health Enhancement for Opioid Use Disorder Patients (PRIME-OUD) (opens NIH RePORTER)
University of Pittsburgh · 1R01DA063606-01A1 · NIDA · Notice Sep 17, 2026
$714KR01
- Dynamic patterns of oral nicotine pouch use and transitions in cigarette and smokeless tobacco use: a fine-grained naturalistic cohort study (opens NIH RePORTER)
University of Vermont · 1R01DA066535-01 · NIDA · Notice Sep 17, 2026
$698KR01
- SMART: strengthening motivation and adherence to HIV prevention and treatment among people who use drugs in Atlanta (opens NIH RePORTER)
Florida State University · 1R34DA067290-01 · NIDA · Notice Sep 17, 2026
$234KR34
- Low-dose ketamine for the treatment of opioid use disorder (opens NIH RePORTER)
University of Maryland, Baltimore · 1R21DA065852-01 · NIDA · Notice Sep 17, 2026
$233KR21
- Exploring mechanisms for oxycodone use disorders after spinal cord injury (opens NIH RePORTER)
Drexel University · 1R21DA064438-01A1 · NIDA · Notice Sep 17, 2026
$229KR21
Looking for a postdoc in addiction and substance use?
See how many addiction and substance use labs received a new NIDA R01 or R00 in the last three months, by month, state, and institution.
Newly funded addiction and substance use labsQuestions about NIDA funding
- How much does NIDA fund?
- In fiscal year 2026, NIDA administered $1.31B across 2,053 award records to the 220 institutions on this page. These are the recipients with $10M or more in total NIH funding, so the figure is a large share of NIDA's extramural awards but not its full budget.
- Which institutions get the most NIDA funding?
- Yale University ($64.3M), University of California San Diego ($63.6M), Johns Hopkins University ($51.4M) led NIDA funding in FY2026.
- How do I find an open NIDA funding opportunity?
- This page lists open and upcoming NOFOs where NIDA is the lead or a participating institute, with the next due date. Most investigator-initiated applications go through the NIH parent announcements instead, and are assigned to an institute after submission; contact a NIDA program officer before you apply to check fit.
More NIH funding rankings
By type
University and health systems
By NIH institute
All institutes · NCI · NIAID · NIA · NHLBI · NIGMS · NINDS · NIDDK · NIMH · OD · NICHD · NCATS · NEI · NIAMS · NIEHS · NHGRI · NIAAA · NIDCD · NIDCR · NIBIB · NIMHD · NCCIH · NINR · NLM · FIC
By state
California · New York · Massachusetts · Pennsylvania · Texas · North Carolina · Maryland · Illinois · Washington · Ohio · Michigan · Florida · Missouri · Connecticut · Georgia · Minnesota · Tennessee · Wisconsin · Virginia · Colorado · New Jersey · Indiana · Oregon · Arizona · Alabama · Utah · Rhode Island · South Carolina · Kentucky · District of Columbia · Louisiana · Iowa · Oklahoma · Kansas · Nebraska · New Hampshire · New Mexico · Maine · Arkansas · Delaware · Mississippi · Vermont · Hawaii · Montana · West Virginia · Puerto Rico · South Dakota · Nevada · Idaho · North Dakota · Alaska · Wyoming